🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Phillip G. Febbo

Veracyte (United States)

ORCID: 0000-0002-6496-4664
MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 3%percentile
1.6Author DataRank

Indexed papers

6in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 6 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

High-throughput SARS-CoV-2 and host genome sequencing from single nasopharyngeal swabs

medRxiv(2020)10.1101/2020.07.27.20163147
Top 25%
0.801DataRank
Top 25%9 citations

Hannah N. De Jong, David Amar, Craig D. Hughes, Alexander G. Ioannidis, Rob Bierman +37 more

Papers

Driven by 11 papers — median percentile 11. Top paper: “High-throughput SARS-CoV-2 and host genome sequencing from single nasopharyngeal swabs”.

High-throughput SARS-CoV-2 and host genome sequencing from single nasopharyngeal swabs

medRxiv(2020)10.1101/2020.07.27.20163147
Top 25%
0.801DataRank
Top 25%9 citations

Hannah N. De Jong, David Amar, Craig D. Hughes, Alexander G. Ioannidis, Rob Bierman +37 more

Predictive Biomarkers of Overall Survival in Patients with Metastatic Renal Cell Carcinoma Treated with IFNα ± Bevacizumab: Results from CALGB 90206 (Alliance)

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-2386
Top 29%
0.694DataRank
Top 29%11 citations

Susan Halabi, Yingmiao Liu, Mark D. Starr, John C. Brady, Ivo Shterev +9 more

Blood-based assessment of patients with mismatch repair-deficient tumors enrolled in NCI-MATCH Arm Z1D (nivolumab).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.2560
Top 78%
0.104DataRank
Top 78%1 citations

Jennifer L. Silhavy, Jennifer S. LoCoco, Biswajit Das, Sorena Rahmanian, Ting-Chia Chang +15 more

Blood-based detection of actionable alterations from NCI-MATCH patients with no tissue results.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.3035
N/A
0DataRank · unranked
0 citations

Amanda Peach, D. A. HOWELL, Biswajit Das, Rini Pauly, Ting-Chia Chang +14 more

Data from Application of Oligonucleotide Microarrays to Assess the Biological Effects of Neoadjuvant Imatinib Mesylate Treatment for Localized Prostate Cancer

(2023)10.1158/1078-0432.c.6518292
Top 100%
0DataRank
Top 100%0 citations

Aaron R. Thorner, Mark A. Rubin, Massimo Loda, Philip W. Kantoff, William Oh +3 more

Data from Predictive Biomarkers of Overall Survival in Patients with Metastatic Renal Cell Carcinoma Treated with IFNα ± Bevacizumab: Results from CALGB 90206 (Alliance)

(2023)10.1158/1078-0432.c.6531354
Top 100%
0DataRank
Top 100%0 citations

Susan Halabi, Yingmiao Liu, Mark D. Starr, John C. Brady, Ivo Shterev +9 more

Data from Predictive Biomarkers of Overall Survival in Patients with Metastatic Renal Cell Carcinoma Treated with IFNα ± Bevacizumab: Results from CALGB 90206 (Alliance)

(2023)10.1158/1078-0432.c.6531354.v1
Top 100%
0DataRank
Top 100%0 citations

Susan Halabi, Yingmiao Liu, Mark D. Starr, John C. Brady, Ivo Shterev +9 more

Contributors

Essentials of Genomic and Personalized Medicine(2010)10.1016/b978-0-12-374934-5.00076-3
N/A
0DataRank · unranked
0 citations

Peter J. Barnes, Ivor J. Benjamin, Mark Boguski, Brigitta Bondy, Roger E. Breitbart +64 more

Integrative analysis of ultra-deep RNA-seq reveals alternative promoter usage as a mechanism of activating oncogenic programmes during prostate cancer progression

Nature Cell Biology(2024)10.1038/s41556-024-01438-3
N/A
0DataRank · unranked
18 citations

Martin Sjöström, Xiekui Cui, Adam Foye, Kyle Kai‐How Farh, Raunak Shrestha +12 more

Contributors

Genomic and Personalized Medicine(2009)10.1016/b978-0-12-369420-1.00122-0
N/A
0DataRank · unranked
0 citations

Matthew L. Anderson, Felicita Andreotti, Brian H. Annex, Anthony Antonellis, Dmitri Artemov +272 more

Genomic epidemiology identifies emergence and rapid transmission of SARS-CoV-2 B.1.1.7 in the United States

medRxiv(2021)10.1101/2021.02.06.21251159
N/A
0DataRank · unranked
106 citations

Karthik Gangavarapu, Mark Zeller, Alexandre Bolze, Elizabeth T. Cirulli, Kelly M. Schiabor Barrett +48 more